Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 847

1.

Yellow fever vaccines and international travelers.

Barnett ED, Wilder-Smith A, Wilson ME.

Expert Rev Vaccines. 2008 Jul;7(5):579-87. doi: 10.1586/14760584.7.5.579. Review.

PMID:
18564013
2.

Yellow fever: the recurring plague.

Tomori O.

Crit Rev Clin Lab Sci. 2004;41(4):391-427. Review.

PMID:
15487593
3.

Prevention of yellow fever in persons traveling to the tropics.

Monath TP, Cetron MS.

Clin Infect Dis. 2002 May 15;34(10):1369-78. Epub 2002 Apr 25. Review. Erratum in: Clin Infect Dis 2002 Jul 1;35(1):110.

PMID:
11981733
4.
5.

Review of the risks and benefits of yellow fever vaccination including some new analyses.

Monath TP.

Expert Rev Vaccines. 2012 Apr;11(4):427-48. doi: 10.1586/erv.12.6. Review.

PMID:
22551029
6.

Allergic reactions to Japanese encephalitis vaccine.

Plesner AM.

Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97. Review. Erratum in: Immunol Allergy Clin North Am. 2004 May;24(2):335.

PMID:
14753386
7.

Yellow fever as an endemic/epidemic disease and priorities for vaccination.

Monath TP.

Bull Soc Pathol Exot. 2006 Dec;99(5):341-7.

PMID:
17253051
8.

An inactivated cell-culture vaccine against yellow fever.

Monath TP, Fowler E, Johnson CT, Balser J, Morin MJ, Sisti M, Trent DW.

N Engl J Med. 2011 Apr 7;364(14):1326-33. doi: 10.1056/NEJMoa1009303.

9.

[Yellow fever--a tropical danger].

Stingl P.

MMW Fortschr Med. 2004 Aug 5;146(31-32):36-7. German.

PMID:
15529706
10.

Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?

Barrett AD, Teuwen DE.

Curr Opin Immunol. 2009 Jun;21(3):308-13. doi: 10.1016/j.coi.2009.05.018. Epub 2009 Jun 10. Review.

PMID:
19520559
11.

Yellow fever: an update.

Monath TP.

Lancet Infect Dis. 2001 Aug;1(1):11-20. Review.

PMID:
11871403
12.

Yellow fever: epidemiology and prevention.

Barnett ED.

Clin Infect Dis. 2007 Mar 15;44(6):850-6. Epub 2007 Feb 1. Review.

PMID:
17304460
13.
14.

New developments in flavivirus vaccines with special attention to yellow fever.

Pugachev KV, Guirakhoo F, Monath TP.

Curr Opin Infect Dis. 2005 Oct;18(5):387-94. Review.

PMID:
16148524
15.

Yellow fever vaccine: past, present and future.

Roukens AH, Visser LG.

Expert Opin Biol Ther. 2008 Nov;8(11):1787-95. doi: 10.1517/14712598.8.11.1787 . Review.

PMID:
18847312
17.

Yellow fever.

Monath TP, Vasconcelos PF.

J Clin Virol. 2015 Mar;64:160-73. doi: 10.1016/j.jcv.2014.08.030. Epub 2014 Oct 24. Review.

PMID:
25453327
18.

Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil.

Galler R, Pugachev KV, Santos CL, Ocran SW, Jabor AV, Rodrigues SG, Marchevsky RS, Freire MS, Almeida LF, Cruz AC, Yamamura AM, Rocco IM, da Rosa ES, Souza LT, Vasconcelos PF, Guirakhoo F, Monath TP.

Virology. 2001 Nov 25;290(2):309-19.

19.

Yellow fever vaccine safety: a reality or a myth?

Arya SC.

Vaccine. 2002 Nov 1;20(31-32):3627-8. Review.

PMID:
12399186
20.

[The risk of yellow fever in travellers].

Roukens AH, Visser LG.

Ned Tijdschr Geneeskd. 2006 Aug 19;150(33):1815-20. Review. Dutch.

PMID:
16967591

Supplemental Content

Support Center